Glomerulonephritis is an important extrahepatic manifestation of chronic hepatitis B virus
(HBV) infection. The uncommon occurrence, variability in renal histopathology, and …

Small interfering RNA (siRNA) constitutes a promising therapeutic modality supporting the
potential functional cure of hepatitis B. A novel ionizable lipidoid nanoparticle (RBP131) and …

Chronic kidney disease (CKD) has become a major public health problem worldwide over
the past few decades because of the increasing prevalence of hypertension, diabetes …

Chronic infection of hepatitis B virus (HBV) is at risk of liver cirrhosis and hepatocellular
carcinoma and remains one of the major public health problems worldwide. It is a major …

Cyclophilin A (CypA), predominantly located intracellularly, is a multifunctional protein. We
previously reported decreased CypA levels in hepatocytes of transgenic mice expressing …

BACKGROUND/AIMS: Hepatitis B virus transgenic mice (HBV-Tg mice) have been widely
used as animal models in the study of pathogenesis and control of hepatitis B. It is important …

Hepatitis B virus (HBV) produces large (L), middle (M), and small (S) envelope proteins,
alternatively referred to as hepatitis B surface antigen (HBsAg). Currently, yeast-derived S …

Summary α‐Galactosylceramide (α‐G al C er)‐activated natural killer T (NKT) cells have
antiviral properties against hepatitis B virus (HBV). However, α‐GalCer activation of NKT …

Chronic hepatitis B (CHB) appears to progress more rapidly in males than in females, and
CHB-related hepatic cirrhosis and hepatocellular carcinoma are predominately diseases …

The anti‐hepatitis B activity of 3, 4‐O‐dicaffeoylquinic acid isolated from Laggera alata was
studied using the d‐galactosamine‐(d‐GalN‐) induced hepatocyte damage model, HepG2 …